Topic Hub
24 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 24 of 24 clinical reviews.
A physician-reviewed comparison of compounded dulaglutide versus branded Trulicity, covering FDA approval status, clinical trial evidence from REWIND, safety differences, cost, and who qualifies for each option.
Read clinical reviewA physician-reviewed guide to using dulaglutide (Trulicity) after bariatric surgery, covering pharmacokinetics, dosing, evidence from REWIND and other trials, and practical prescribing considerations for post-bariatric patients with type 2 diabetes.
Read clinical reviewA clinician-level review of dulaglutide (Trulicity) use in patients with autoimmune conditions, covering thyroid disease, IBD, lupus, RA, and safety signals from REWIND and post-marketing data.
Read clinical reviewA clinician-level review of how dulaglutide (Trulicity) affects sexual function in men and women with type 2 diabetes, covering the REWIND trial, hormonal pathways, erectile dysfunction, libido changes, and practical management guidance.
Read clinical reviewA physician-reviewed, primary-literature analysis of dulaglutide's effect on cognition, brain health, and dementia risk in type 2 diabetes, including REWIND trial data and mechanistic research.
Read clinical reviewA clinical deep-dive into how dulaglutide (Trulicity) changes appetite, food cravings, and eating behavior in type 2 diabetes. Includes trial data, mechanism, dose effects, and practical management.
Read clinical reviewA clinician-level review of dulaglutide (Trulicity) and its effects on bone mineral density, fracture risk, and skeletal metabolism, with primary-literature citations and practical prescribing guidance.
Read clinical reviewA physician-level review of dulaglutide (Trulicity) and cancer risk, covering thyroid, pancreatic, and colorectal signals from REWIND, FDA labeling, and post-marketing surveillance data.
Read clinical reviewA deep-dive into dulaglutide's long-term cardiovascular effects, anchored in the REWIND trial and supporting literature. Learn what a 12% MACE reduction means clinically, who benefits most, and how dulaglutide compares to other GLP-1 receptor agonists.
Read clinical reviewA GRADE-level analysis of dulaglutide (Trulicity) clinical evidence, covering cardiovascular outcomes, glycemic efficacy, weight, safety, and how the data stacks up for shared decision-making in type 2 diabetes.
Read clinical reviewA physician-reviewed guide to dulaglutide (Trulicity) effects on hair and skin, covering clinical trial data, proposed mechanisms, and what patients can expect.
Read clinical reviewA clinical deep-dive into how dulaglutide (Trulicity) affects liver enzymes, hepatic fat, and NAFLD/MASH. Covers REWIND trial data, ALT/AST findings, and prescribing guidance for patients with liver disease.
Read clinical reviewA clinician-level review of how dulaglutide (Trulicity) affects mental health and mood, covering GLP-1 receptor signaling in the brain, trial data, FDA safety communications, and practical monitoring guidance.
Read clinical reviewA physician-reviewed deep dive into how dulaglutide (Trulicity) affects metabolism, energy expenditure, thermogenesis, and weight. Includes REWIND trial data, mechanism-of-action details, and clinical dosing guidance.
Read clinical reviewA clinical review of dulaglutide (Trulicity) microdosing protocols, approved dosing regimens, REWIND trial data, and what physicians should know about off-label low-dose use in type 2 diabetes and weight management.
Read clinical reviewEvidence-based strategies to preserve lean mass while on Trulicity (dulaglutide), including resistance training protocols, protein targets, and monitoring checkpoints reviewed by HealthRX physicians.
Read clinical reviewWhy dulaglutide (Trulicity) stops working and what to do about it. MD-level plateau troubleshooting covering dose optimization, GLP-1 receptor tachyphylaxis, combination strategies, and switch protocols backed by primary trial data.
Read clinical reviewEvidence-based guidance on how long to hold dulaglutide (Trulicity) before surgery, why delayed gastric emptying raises aspiration risk, and how to manage blood glucose in the perioperative period.
Read clinical reviewStopping dulaglutide (Trulicity) can trigger glycemic rebound, weight regain, and cardiovascular risk recurrence. Learn what the clinical data say, how fast it happens, and how to discontinue safely.
Read clinical reviewA physician-level review of dulaglutide's effects on kidney function, including REWIND trial data, GFR trajectories, albuminuria outcomes, and clinical guidance for patients with CKD.
Read clinical reviewWhen and how to safely restart dulaglutide (Trulicity) after acute illness, hospitalization, or GI upset. Evidence-based dosing protocols, monitoring parameters, and red flags from the REWIND trial and ADA guidelines.
Read clinical reviewA clinical guide to dulaglutide (Trulicity) seasonal use considerations, covering heat stability, cold-weather injection technique, holiday eating patterns, illness management, and cardiovascular evidence from REWIND.
Read clinical reviewA physician-reviewed deep dive into how dulaglutide (Trulicity) affects sleep architecture, including GLP-1 receptor distribution in sleep-regulatory brain regions, weight-loss-driven OSA data, and practical clinical guidance.
Read clinical reviewA clinician-reviewed, week-by-week guide to dulaglutide (Trulicity) in your first month: side effects, blood sugar changes, dosing milestones, and what the evidence from REWIND and AWARD trials actually shows.
Read clinical review